首页> 外文期刊>Acta Pharmacologica Sinica >Effects of simvastatin on cardiac performance and expression of sarco-plasmic reticular calcium regulatory proteins in rat heart
【24h】

Effects of simvastatin on cardiac performance and expression of sarco-plasmic reticular calcium regulatory proteins in rat heart

机译:辛伐他汀对大鼠心脏功能和肌浆网状钙调节蛋白表达的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: To investigate the effect of simvastatin on the cardiac contractile function and the alteration of gene and protein expression of the sarcoplasmic calcium regulatory proteins, including sarcoplasmic reticulum Ca~(2+)-ATPase (SERCA), phospholamban (PLB), and ryanodine receptor 2 (RyR2) in rat hearts. Methods: Langendorff-perfused rat hearts were subjected to 60-min perfusion with different concentrations of simvastatin (1,3,10, 30, or 100 μmol/L), and the parameters of cardiac function such as left ventricular developed pressure (LVDP), +dp/dt_(max), and -dp/dt_(max) were determined. The cultured neonatal rat ventricular cardiomyo-cytes were incubated with simvastatin (1,3,10,30, and 100 μmol/L) for 1 h Or 24 h. The levels of SERCA, PLB, and RyR2 expression were measured by reverse tran-scription-polymerase chain reaction and Western blot. Cytotoxic effect of simvastatin on ventricular cardiomyocytes was assessed by the MTT colorimetric assay. Results: LVDP, +dp/dt_(max), and -dp/dt_(max) of hearts were increased significantly after treatment with simvastatin 3,10, and 30 μmol/L. In simvastatin-treated isolated hearts, the levels of mRNA expression of SERCA and RyR2 were elevated compared with the control (P < 0.05), while the mRNA expression of PLB did not change. After the cultured neonatal rat ventricular cardiomyocytes were incubated with 3,10,30, and 100 μmol/L simvastatin for 1 h, SERCA and RyR2 mRNA expressions of cardiomyocytes rose, but there was no alteration in protein expressions. However, with the elongation of simvastatin treatment to 24 h, the protein expression of SERCA and RyR2 were also elevated. Additionally, simvastatin (1-30 μmol/L) had no influence on cell viability of cultured cardiac myocytes, but simvastatin 100 μmol/L inhibited the cell viability. Conclusion: Simvastatin improved cardiac performance accompanied by the elevation of SERCA and RyR2 gene and protein expression.
机译:目的:研究辛伐他汀对心肌收缩功能的影响,以及肌浆钙调节蛋白,包括肌浆Ca〜(2 +)-ATPase(SERCA),磷酸lamban(PLB)和ryanodine的基因和蛋白表达的变化。大鼠心脏中的受体2(RyR2)。方法:用不同浓度的辛伐他汀(1、3、10、30或100μmol/ L)对Langendorff灌注的大鼠心脏进行60分钟的灌注,并测量心脏功能参数,例如左心室发育压力(LVDP) ,+ dp / dt_(max)和-dp / dt_(max)。培养的新生大鼠心室心肌细胞与辛伐他汀(1、3、10、30和100μmol/ L)孵育1小时或24小时。 SERCA,PLB和RyR2表达水平通过逆转录聚合酶链反应和Western印迹法测量。通过MTT比色测定法评估辛伐他汀对心室心肌细胞的细胞毒性作用。结果:辛伐他汀3,10和30μmol/ L治疗后,心脏的LVDP,+ dp / dt_(max)和-dp / dt_(max)显着增加。在辛伐他汀治疗的离体心脏中,SERCA和RyR2的mRNA表达水平比对照组高(P <0.05),而PLB的mRNA表达没有变化。培养的新生大鼠心室心肌细胞与3、10、30和100μmol/ L辛伐他汀孵育1小时后,心肌细胞的SERCA和RyR2 mRNA表达上升,但蛋白表达没有改变。然而,随着辛伐他汀治疗延长至24 h,SERCA和RyR2的蛋白表达也升高。另外,辛伐他汀(1-30μmol/ L)对培养的心肌细胞的细胞活力没有影响,但是辛伐他汀100μmol/ L抑制了细胞活力。结论:辛伐他汀可改善心脏功能,并伴有SERCA和RyR2基因和蛋白质表达的升高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号